Cargando…

No Association between the Response to the Addition of an Atypical Antipsychotic Drug to an SSRI or SNRI and the BDNF (Val66Met) Polymorphism in Refractory Major Depressive Disorder in Japanese Patients

OBJECTIVE: This study examined the association between the brain-derived neurotrophic factor (BDNF) (Val66Met) polymorphism and the response to the addition of an atypical antipsychotic drug to a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI) in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshimura, Reiji, Kishi, Taro, Hori, Hikaru, Ikenouchi-Sugita, Atsuko, Umene-Nakano, Wakako, Katsuki, Asuka, Hayashi, Kenji, Iwata, Nakao, Nakamura, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569156/ https://www.ncbi.nlm.nih.gov/pubmed/23429762 http://dx.doi.org/10.9758/cpn.2012.10.1.49

Ejemplares similares

Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients
por: Yoshimura, Reiji, et al.
Publicado: (2014)

COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study
por: Hayashi, Kenji, et al.
Publicado: (2014)

Serum Levels of Brain-Derived Neurotrophic Factor at 4 Weeks and Response to Treatment with SSRIs
por: Yoshimura, Reiji, et al.
Publicado: (2014)

Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder
por: Atake, Kiyokazu, et al.
Publicado: (2014)

Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia
por: Goto, Naoki, et al.
Publicado: (2012)

Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review
por: Tokutsu, Yuki, et al.
Publicado: (2013)

Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes
por: Ikenouchi-Sugita, Atsuko, et al.
Publicado: (2008)

The brain-derived neurotrophic factor Val66Met polymorphism increases segregation of structural correlation networks in healthy adult brains
por: Ueda, Issei, et al.
Publicado: (2020)

Risks of using SSRI / SNRI antidepressants during pregnancy and lactation
por: Dubovicky, Michal, et al.
Publicado: (2017)

Plasma concentrations of SSRI/SNRI after bariatric surgery and the effects on depressive symptoms
por: Pasi, Patrick, et al.
Publicado: (2023)

Serum levels of brain-derived neurotrophic factor (BDNF), proBDNF and plasma 3-methoxy-4-hydroxyphenylglycol levels in chronic schizophrenia
por: Yoshimura, Reiji, et al.
Publicado: (2016)

Placebo Responses and Their Clinical Implications in Fibromyalgia: A Meta-Analysis Using SSRI and SNRI Trials
por: Koechlin, Helen, et al.
Publicado: (2021)

Abnormal White Matter Integrity in the Corpus Callosum among Smokers: Tract-Based Spatial Statistics
por: Umene-Nakano, Wakako, et al.
Publicado: (2014)

Does subjective sleep quality improve by a walking intervention? A real-world study in a Japanese workplace
por: Hori, Hikaru, et al.
Publicado: (2016)

Comparative Assessment of Adherence Measures and Resource Use in SSRI/SNRI-Treated Patients with Depression Using Second-Generation Antipsychotics or L-Methylfolate as Adjunctive Therapy
por: Wade, Rolin L., et al.
Publicado: (2014)

Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorder
por: Atake, Kiyokazu, et al.
Publicado: (2015)

The relationship of SSRI and SNRI usage with interstitial lung disease and bronchiectasis in an elderly population: a case–control study
por: Rosenberg, Ted, et al.
Publicado: (2017)

Genetic Variation in the Catechol-O-Methyl Transferase Val108/158Met Is Linked to the Caudate and Posterior Cingulate Cortex Volume in Healthy Subjects: Voxel-Based Morphometry Analysis of Brain Magnetic Resonance Imaging
por: Watanabe, Keita, et al.
Publicado: (2015)

Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden
por: Zoega, Helga, et al.
Publicado: (2015)

Use of SSRI, But Not SNRI, Increased Upper and Lower Gastrointestinal Bleeding: A Nationwide Population-Based Cohort Study in Taiwan
por: Cheng, Yuan-Lung, et al.
Publicado: (2015)

Do Triptan Antimigraine Medications Interact with SSRI/SNRI Antidepressants? What Does Your Decision Support System Say?
por: Kogut, Stephen J.
Publicado: (2011)

Association between the Val66Met polymorphism (rs6265/G196A) of the BDNF gene and cognitive performance with SSRI use in Arab Alzheimer’s disease patients
por: Abanmy, N., et al.
Publicado: (2021)

Serum Brain-Derived Neurotrophic Factor, and Plasma Catecholamine Metabolites in People with Major Depression: Preliminary Cross-Sectional Study
por: Yoshimura, Reiji, et al.
Publicado: (2018)

Pre-clinical evaluation of CYP 2D6 dependent drug–drug interactions between primaquine and SSRI/SNRI antidepressants
por: Jin, Xiannu, et al.
Publicado: (2016)

Effects of the BDNF Val66Met Polymorphism on Gray Matter Volume in Typically Developing Children and Adolescents
por: Hashimoto, Teruo, et al.
Publicado: (2016)

The Val66 and Met66 Alleles-Specific Expression of BDNF in Human Muscle and Their Metabolic Responsivity
por: de Assis, Gilmara Gomes, et al.
Publicado: (2021)

BDNF Val66Met polymorphism and protein levels in Amniotic Fluid
por: Cattaneo, Annamaria, et al.
Publicado: (2010)

Association between the BDNF Val66Met Polymorphism and Chronicity of Depression
por: Lee, Yujin, et al.
Publicado: (2013)

BDNF Val66Met Variant and Smoking in a Chinese Population
por: Zhang, Xiang Yang, et al.
Publicado: (2012)

BDNF Val(66)Met Polymorphism Is Associated with Self-Reported Empathy
por: Taschereau-Dumouchel, Vincent, et al.
Publicado: (2016)

Association of BDNF Val66Met Polymorphism and Brain BDNF Levels with Major Depression and Suicide
por: Youssef, Mariam M, et al.
Publicado: (2018)

The BDNF Val66Met polymorphism affects negative memory bias in civilian women with PTSD
por: Hori, Hiroaki, et al.
Publicado: (2020)

Discontinuation Rates and Health Care Costs in Adult Patients Starting Generic Versus Brand SSRI or SNRI Antidepressants in Commercial Health Plans
por: Kautzner, Adam, et al.
Publicado: (2011)

Neuroprotective effect of Val variant of BDNF Val66Met polymorphism on hippocampus is modulated by the severity of menstrual pain
por: Li, Wei-Chi, et al.
Publicado: (2021)

Allelic distribution of BDNF Val66Met polymorphism in healthy Romanian volunteers
por: Vulturar, Romana, et al.
Publicado: (2016)

Childhood trauma interacted with BDNF Val66Met influence schizophrenic symptoms
por: Bi, Xiao-jiao, et al.
Publicado: (2018)

Critical Issues in BDNF Val66Met Genetic Studies of Neuropsychiatric Disorders
por: Tsai, Shih-Jen
Publicado: (2018)

Interactions of BDNF Val66Met Polymorphism and Menstrual Pain on Brain Complexity
por: Low, Intan, et al.
Publicado: (2018)

BDNF val66met association with serotonin transporter binding in healthy humans
por: Fisher, P M, et al.
Publicado: (2017)

The BDNF Val66Met Polymorphism Affects the Vulnerability of the Brain Structural Network
por: Park, Chang-hyun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a5pl51qgbkq8rpo29flugbmutv